Sleep apnea

Proceedings of the American Thoracic Society

Volumn 3, Issue 1, 2006, Pages 124-128

  White, David P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apnea; Diagnosis; Loop gain; Pharyngeal muscles; Treatment

Indexed keywords

AROUSAL; ARTERIAL OXYGEN SATURATION; BEHAVIOR THERAPY; COGNITION; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; HEART INFARCTION; HUMAN; HYPOXIA; MANDIBLE; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REM SLEEP; REVIEW; SLEEP APNEA SYNDROME; SOMNOLENCE; STROKE; SURGICAL TECHNIQUE; UPPER RESPIRATORY TRACT; UVULOPALATOPHARYNGOPLASTY;

BEHAVIOR CONTROL; DIAGNOSIS, DIFFERENTIAL; HUMANS; MUSCLE CONTRACTION; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PHARYNGEAL MUSCLES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES;

EID: 33644515314     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200510-116JH     Document Type: Review

References (41)

1. Malhotra A, White D. Seminar: obstructive sleep apnoea. Lancet 2002;360:237-245.
2. Berry RB, Gleeson K. Respiratory arousal from sleep: mechanisms and significance. Sleep 1997;20:654-675.
3. Haponik E, Smith PL, Bohlman ME, Allen RP, Goldman SM, Blecker ER. Computerized tomography in obstructive sleep apnea: correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis 1983;127:221-226.
4. Isono S, et al. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol 1997;82:1319-1326.
5. Welch K, et al. Anovel volumetric magnetic resonance imaging paradigm to study upper airway anatomy. Sleep 2002;25:532-542.
6. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal EMG in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanisms). J Clin Invest 1992;89:1571-1579.
7. Remmers JE, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44:931-938.
8. Malhotra A, et al. Pharyngeal pressure and flow effects on genioglossus activation in normal subjects. Am J Respir Crit Care Med 2002;165:71-77.
9. Malhotra A, et al. Genioglossal but not palatal muscle activity relates closely to pharyngeal pressure. Am J Respir Crit Care Med 2000;162:1058-1062.
10. Malhotra A, et al. Local mechanisms drive genioglossus muscle activation in obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1746-1749.
11. Onal E, Lopata M, O'Connor TD. Diaphragmatic and genioglossal electromyogram responses to CO2 rebreathing in humans. J Appl Physiol 1981;50:1052-1055.
12. Onal E, Lopata M, O'Connor T. Diaphragmatic and genioglossal electromyogram responses to isocapnic hypoxia in humans. Am Rev Respir Dis 1981;124:215-217.
13. Akahoshi T, White DP, Edwards JK, Beauregard J, Shea SA. Phasic mechanoreceptor stimuli can induce phasic activation of upper airway muscles in humans. J Physiol 2001;531:677-691.
14. Fogel R, et al. Genioglossal activation in patients with obstructive sleep apnea versus control subjects: mechanisms of muscle control. Am J Respir Crit Care Med 2001;164:2025-2030.
15. Horner R, et al. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol 1994;476:141-151.
16. Stanchina M, et al. Genioglossus muscle responsiveness to chemical and mechanical loading during NREM sleep. Am J Respir Crit Care Med 2002;165:945-949.
17. Berry RB, et al. Upper airway anesthesia reduces phasic genioglossus activity during sleep apnea. Am J Respir Crit Care Med 1997;156:127-132.
18. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med 2004;169:623-633.
19. Gleeson K, Zwillich CW, White DP. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 1990;142:295-300.
20. Khoo MC, et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 1982;53:644-659.
21. Younes M, et al. Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2001;163:1181-1190.
22. Hudgel DW, et al. Instability of ventilatory control in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1998;158:1142-1149.
23. Wellman A, et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:1225-1232.
24. Jenkinson C, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-2105.
25. Brooks D, et al. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997;99:106-109.
26. Lavie P, Here P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension. BMJ 2000;320:479-482.
27. Nieto F, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-1836.
28. Peppard P, et al. Longitudinal study of moderate weight change and sleep disordered breathing. JAMA 2000;284:3015-3021.
29. Faccenda J, Boon NA, Mackay TW, Douglas NJ. CPAP effects on blood pressure in the sleep apnea/hypopnoea syndrome during a randomized controlled trial. Am J Respir Crit Care Med 2001;163:344-348.
30. Pepperell JC, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-210.
31. Becker H, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
32. Shahar E, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
33. Vgontzas AN, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
34. Shamsuzzaman A, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464.
35. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
36. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992;47:101-105.
37. Young T, Peppard P, Gottlieb D. The epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-1239.
38. Ayas N, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep 2004;27:249-253.
39. Ferguson KA, et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mildmoderate obstructive sleep apnea. Chest 1996;109:1269-1275.
40. Sundaram S, et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005;4:CD001004.
41. Powell NB, Riley RW, Robinson A. Surgical management of obstructive sleep apnea syndrome. Clin Chest Med 1998;19:77-86.